Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Intero Biosystems is a startup that is providing lab-grown human intestines to drugmakers, replacing the need for animal testing. The company is scaling up its production and expanding its organoid technology, which is being driven by regulatory pressures to move away from animal testing. This shift is expected to benefit drug development and reduce the use of animal subjects in research.